<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B684FE39-2541-4CC8-90CC-B7924B7C61A3"><gtr:id>B684FE39-2541-4CC8-90CC-B7924B7C61A3</gtr:id><gtr:name>Ithaca College</gtr:name><gtr:address><gtr:line1>Ithaca College</gtr:line1><gtr:line2>Ithaca</gtr:line2><gtr:postCode>14850</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:department>Research and Enterprise Services</gtr:department><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B684FE39-2541-4CC8-90CC-B7924B7C61A3"><gtr:id>B684FE39-2541-4CC8-90CC-B7924B7C61A3</gtr:id><gtr:name>Ithaca College</gtr:name><gtr:address><gtr:line1>Ithaca College</gtr:line1><gtr:line2>Ithaca</gtr:line2><gtr:postCode>14850</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/EA1A021B-0494-46D4-8944-16A06A168152"><gtr:id>EA1A021B-0494-46D4-8944-16A06A168152</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:otherNames>Courtenay</gtr:otherNames><gtr:surname>Robson</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/435AB6B5-B2AF-4107-8446-B3450FD7D465"><gtr:id>435AB6B5-B2AF-4107-8446-B3450FD7D465</gtr:id><gtr:firstName>Magdalena</gtr:firstName><gtr:surname>Karolczak-Bayatti</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/B57F5972-B37F-42BE-9B04-8CDA47BE9E06"><gtr:id>B57F5972-B37F-42BE-9B04-8CDA47BE9E06</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:surname>Taggart</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/09722535-56AC-4D17-9A4B-680629BCECB3"><gtr:id>09722535-56AC-4D17-9A4B-680629BCECB3</gtr:id><gtr:firstName>Nick</gtr:firstName><gtr:surname>Europe-Finner</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0800202"><gtr:id>DB0C9928-D977-4CDD-AF02-834ACC1C2446</gtr:id><gtr:title>Novel regulation of human myometrial contractility by histone deacetylase 8 (HDAC8)</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0800202</gtr:grantReference><gtr:abstractText>Approximately 6-10% of human pregnancies end with delivery before ?full term?, and premature born babies suffer from long term physical and mental handicap. Furthermore, up to 65% of perinatal births are related to premature birth. To date, drugs used to stop contractions, termed tocolytics, are still not effective and safe enough and cause non-specific and often dangerous side effects for both mother and infant. Recent investigations on vascular smooth muscle cells has indicated that a specific protein histone deacetylase 8 (HDAC8) is a specific marker of smooth muscle and is essential for the contractility of this muscle cell type. Our initial data also indicates that this protein may play an important role in regulating uterine smooth muscle activity during pregnancy and labour. Consequently the purpose of the research proposal are to define whether this is the case and to determine whether highly selective HDAC8 inhibitors can act as potential novel therapeutic agents in the better management of premature labour.</gtr:abstractText><gtr:technicalSummary>It is now becoming increasingly recognized that regulation of proteins by acetylation on lysine residues may be a key effector in regulating their activity and that histone deacetylases (HDACs) play a pivotal role in this process. In this respect the epigenetic effects of inhibitors on gene expression via increased histone acetylation and chromatin remodeling are now well known. However, growing evidence also indicates that non-histone proteins are additional targets for HDACs. Recently, HDAC8, a member of the predominantly nuclear bound family of class I HDACs, has been found to be a cytosolic marker of smooth muscle differentiation and associates with the cytoskeleton-protein smooth muscle alpha-actin in human vascular smooth muscle cells and is essential for its contractility. In this respect our pilot studies in human myometrial smooth muscle cells has demonstrated that HDAC8 is also present in these cells and is localised predominantly in the cytoplasmic/cytoskeletal region rather than in the nucleus in contrast to HDAC1. Consequently the goals of the research proposal are to define whether HDAC8 plays an important role in regulating the contractile machinery in the myometrium and to define whether highly selective HDAC8 inhibitors can perturb this mechanism and thus act as potential tocolytics.</gtr:technicalSummary><gtr:fund><gtr:end>2011-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>451302</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Obstetrics and Gynaecology</gtr:department><gtr:description>Co-chief investigator on a NH-MRC grant (Australia)</gtr:description><gtr:id>02483141-9934-485B-9316-074F3E4E45F4</gtr:id><gtr:impact>N/A</gtr:impact><gtr:outcomeId>gqoZQLNyU8g-1</gtr:outcomeId><gtr:partnerContribution>N/A</gtr:partnerContribution><gtr:piContribution>I am a co-chief investigator on a project grant entitled &amp;quot;Understanding the regulation of hERG potassium channel in the myometrium at the time of labour&amp;quot;with Professor Roger Smith, Dr Susan Hua and Dr Mingtao Liang (University of Newcastle, New South Wales, Australia) funded by the NH-MRC (Australia)</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Ithaca College</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Chemistry</gtr:department><gtr:description>Compound 2</gtr:description><gtr:id>737C4C83-C7EA-4637-9DFB-31001E354BDE</gtr:id><gtr:impact>The work from this collaboration has resulted in peer review publications and presentation at international meetings

Peer Review
Karolczak-Bayatti.,M, Sweeney., M, Cheng.,J, Edey.,L, Robson., S.,C., Ulrich.,S., M., Treumann., A., Taggart., M., J and Europe-Finner.,G. N. (2011). 
Acetylation of heat shock protein 20 (Hsp20) regulates human myometrial activity. J. Biol. Chem. 286 (39). 34346
-34355.doi:10.1074/jbc.M111.278549.

Conference abstracts
Magdalena Karolczak-Bayatti, Michael J Taggart, Steven C Robson, Scott M Ulrich, and G Nicholas Europe-Finner (2009)
 Novel Regulation of Human Myometrial Function by Histone Deacetylase 8 (HDAC8) - A Potential Contractile Modulatory Role for Specific HDAC8 Inhibition. Reproduct. Sci. 15 (2), 774.

Karolczak-Bayatti M, Taggart MJ, Robson SC, Ulrich SM and Europe-Finner GN (2010).
Evaluation of linkerless hydroxamic acid derivatives as selective HDAC8 inhibitors in regulating myometrial contractility. Reproduct. Sci. 17 (3), 53.</gtr:impact><gtr:outcomeId>owP5w36Wv4U-1</gtr:outcomeId><gtr:partnerContribution>Compound 2 a specific HDAC8 inhibitor synthesised by Dr Scott Ulrich at Ithaca College (USA) was found to be a potent inhibitor of human myometrial contractions via increased acetylation of Hsp20</gtr:partnerContribution><gtr:piContribution>Compound 2 a specific HDAC8 inhibitor was used in a MRC funded project grant a found to be a potential uterine tocolytic</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Seminar by Applicant Europe-Finner</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>F4A1CE8F-8D31-4625-BD43-6793007263A4</gtr:id><gtr:impact>Delivered research seminar to Department of Human Development &amp;amp; Metabolism, University of Sheffield.

Research exchange with peers.</gtr:impact><gtr:outcomeId>KNLCt5nTzER</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited seminar by co-applicant Karolczak-Bayatti</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>F9D31CD0-BECB-4A61-B402-BACE6A63D99E</gtr:id><gtr:impact>Delivered research seminar to Department of Obstetrics &amp;amp; Gynaecology, Chelsea &amp;amp; Westminster Hospital, Imperial College London.

Exchange of research information with peers.</gtr:impact><gtr:outcomeId>H1DnedcHJiw</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>183040</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>Action Medical Research</gtr:fundingOrg><gtr:fundingRef>GN2217</gtr:fundingRef><gtr:id>2A43F7A7-019C-411E-8817-31E75DCEB686</gtr:id><gtr:outcomeId>545cb46f96d135.02086223</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>175499</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2013-02-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:fundingRef>PG/09/075</gtr:fundingRef><gtr:id>AAB3A2D5-6D83-4977-B9EB-B309CB1D431F</gtr:id><gtr:outcomeId>tEwGxUuJtmd0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>228024</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Collaboration Grant</gtr:description><gtr:end>2012-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0900525</gtr:fundingRef><gtr:id>7454CF71-2CBF-4D9A-B6C4-E7532211C6F8</gtr:id><gtr:outcomeId>76B3C46E5AA0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>728679</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2018-03-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/L0009560/1</gtr:fundingRef><gtr:id>D8AD2A13-04FD-4B17-8EDB-0F46700BF24D</gtr:id><gtr:outcomeId>545cb36256cab9.58858289</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>371641</gtr:amountPounds><gtr:country>Australia, Commonwealth of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>National Health and Medical Research Council</gtr:department><gtr:description>Project grant</gtr:description><gtr:end>2015-11-02</gtr:end><gtr:fundingOrg>Australian Government</gtr:fundingOrg><gtr:fundingRef>APP1050584</gtr:fundingRef><gtr:id>F3C94B2E-10BA-4FF4-A19B-C0C95451324A</gtr:id><gtr:outcomeId>rMmgdeoHxkz</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2012-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Professor Taggart is a member of the Royal Society of Biology Primary Curriculum Group</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>AA55DF13-7AD2-43C0-8989-5BACE6C87D79</gtr:id><gtr:outcomeId>56bc7f576e14e5.65469868</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type><gtr:url>https://www.rsb.org.uk/about-us/committees/primary-working-group</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We are in the process of commissioning the production of, and validating the efficacy of, anti-acetylated antibodies to the lysine residues of human Hsp20 and guinea pig Hsp20.</gtr:description><gtr:id>8F9644D9-1CD5-4410-AFC8-CCCF3E2DA751</gtr:id><gtr:impact>The antibodies are currently under first stage production and about to be tested for efficacy.</gtr:impact><gtr:outcomeId>XVtQX2J37N3</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Acetylated Lysine Hsp20 antibody</gtr:title><gtr:type>Antibody</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>C20F9F78-E3BF-4B75-A6ED-A85116C134AE</gtr:id><gtr:title>Letter to the editor: &amp;quot;KDAC and the regulation of nonnuclear smooth muscle protein acetylation&amp;quot;.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Cell physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cd6c950536f20699d2eb7ee5c92ba14b"><gtr:id>cd6c950536f20699d2eb7ee5c92ba14b</gtr:id><gtr:otherNames>Taggart MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0363-6143</gtr:issn><gtr:outcomeId>545cb17e0b8fd7.65678947</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2B996EB-0706-459F-974F-22146A8E0EF0</gtr:id><gtr:title>The multifaceted KDAC8: a smooth muscle contractile regulator.</gtr:title><gtr:parentPublicationTitle>Trends in pharmacological sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b73d4a97a6c838ff07e3ec4fe42a7a6"><gtr:id>5b73d4a97a6c838ff07e3ec4fe42a7a6</gtr:id><gtr:otherNames>Europe-Finner GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0165-6147</gtr:issn><gtr:outcomeId>56b890e3551af2.84758683</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>081657BB-D9A9-4DEE-8FF8-571B8A2E64A2</gtr:id><gtr:title>A role for cytoskeletal protein acetylation in modulating myometrial activity.</gtr:title><gtr:parentPublicationTitle>Reproductive sciences (Thousand Oaks, Calif.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b73d4a97a6c838ff07e3ec4fe42a7a6"><gtr:id>5b73d4a97a6c838ff07e3ec4fe42a7a6</gtr:id><gtr:otherNames>Europe-Finner GN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1933-7191</gtr:issn><gtr:outcomeId>pm_12487_27_22412188</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>77210457-C01E-4395-9EA0-944083B987F7</gtr:id><gtr:title>Expression of the GTP-binding protein Gas in human myometrial cells is regulated by ubiquitination and protein degradation: involvement of proteasomal inhibition by trichostatin A.</gtr:title><gtr:parentPublicationTitle>Reproductive sciences (Thousand Oaks, Calif.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3b99fb2ae2e3dec5132845468f14194"><gtr:id>f3b99fb2ae2e3dec5132845468f14194</gtr:id><gtr:otherNames>Karolczak-Bayatti M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1933-7191</gtr:issn><gtr:outcomeId>pm_12487_27_22875848</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85E53BFE-1034-49DC-821D-0DC4057F0A17</gtr:id><gtr:title>The transcription factor encyclopedia.</gtr:title><gtr:parentPublicationTitle>Genome biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/96b603a84b0ff7b8a60599e8e9c0b80b"><gtr:id>96b603a84b0ff7b8a60599e8e9c0b80b</gtr:id><gtr:otherNames>Yusuf D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1474-7596</gtr:issn><gtr:outcomeId>pm_12487_27_22458515</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2C5374E-8EC6-4E7B-8452-6B7C782B5304</gtr:id><gtr:title>Acetylation of heat shock protein 20 (Hsp20) regulates human myometrial activity.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f3b99fb2ae2e3dec5132845468f14194"><gtr:id>f3b99fb2ae2e3dec5132845468f14194</gtr:id><gtr:otherNames>Karolczak-Bayatti M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>h9QULQyBzZJ</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0800202</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>FA7AA693-7EDD-4A7E-8CA3-6B5658FBF717</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Reproductive Health and Childbirth</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>8F896112-5A04-4A11-A9F0-2B446D9AAC8A</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>5.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>